|
1
|
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.
|
J Clin Invest
|
2003
|
2.87
|
|
2
|
Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.
|
J Biol Chem
|
2006
|
2.75
|
|
3
|
TWEAK induces liver progenitor cell proliferation.
|
J Clin Invest
|
2005
|
2.68
|
|
4
|
Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function.
|
J Immunol
|
2004
|
1.53
|
|
5
|
Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies.
|
Arthritis Res
|
2001
|
1.47
|
|
6
|
BAFF production by antigen-presenting cells provides T cell co-stimulation.
|
Int Immunol
|
2004
|
1.29
|
|
7
|
BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
|
Int Immunol
|
2005
|
1.28
|
|
8
|
The TNF family members BAFF and APRIL: the growing complexity.
|
Cytokine Growth Factor Rev
|
2003
|
1.26
|
|
9
|
Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF.
|
J Biol Chem
|
2003
|
1.17
|
|
10
|
Dual role for TWEAK in angiogenic regulation.
|
J Cell Sci
|
2002
|
1.16
|
|
11
|
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.
|
Circulation
|
2009
|
1.12
|
|
12
|
Transition to adult services among behaviorally infected adolescents with HIV--a qualitative study.
|
J Pediatr Psychol
|
2009
|
1.02
|
|
13
|
Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade.
|
Blood
|
2007
|
1.01
|
|
14
|
Posttraumatic stress and trauma history in adolescents and young adults with HIV.
|
AIDS Patient Care STDS
|
2007
|
1.00
|
|
15
|
Description of a novel pediatric emergency department-based HIV screening program for adolescents.
|
AIDS Patient Care STDS
|
2008
|
0.90
|
|
16
|
The biochemistry and biology of BAFF, APRIL and their receptors.
|
Curr Dir Autoimmun
|
2005
|
0.84
|
|
17
|
EC144 is a potent inhibitor of the heat shock protein 90.
|
J Med Chem
|
2012
|
0.81
|
|
18
|
BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders.
|
Expert Opin Ther Targets
|
2003
|
0.79
|